Market Overview

Top Trending Tickers On StockTwits For February 5

Related CVS
#PreMarket Primer: Tuesday, October 21: China's Third Quarter Growth Disappoints
IBM's Report Weighs On The Dow, Apple Helps Boost The Nasdaq, S&P 500 Extends Winning Streak
Making Money With Charles Payne: 10/08/14 (Fox Business)

Here's a look at the top tickers trending on StockTwits.com

Tableau Software: Trouncing estimates

Last night, Tableau Software (NASDAQ: DATA) reported its fourth quarter results. The company announced an EPS of $0.20, beating the consensus estimate of $0.00. Revenue of $81.45 million beat the consensus estimate of $66.95 million.

Tableau Software's revenue grew 95 percent year over year and 90 percent from the third quarter. Licenses revenue which represents 71 percent of total revenue grew 93 percent, up from the third quarter's 90 percent. Maintenance revenue which represents the remaining 29 percent of total revenue doubled to $23.4 million after growing 91 percent in the third quarter.

"We're very pleased with our performance in the fourth quarter, as we sustained our rapid growth," said Christian Chabot, CEO and President. "We continue to see an expansion of our market opportunity and look forward to helping more customers turn data into revealing business insights in the next year."

This morning, analyst at JMP Securities increased their price target to $105 from a previous $80. The analysts thinks that the company's customer base is rapidly expanding translating to a very positive and upbeat outlook.

Shares were trading higher by 12.65 percent in the pre-market session.

CVS: Removing tobacco products

CVS Caremark (NYSE: CVS) announced that it plans to remove tobacco products from its shelves. The move will cost the company billions of dollars in revenue once the company phases out all tobacco sales by October 1.

"CVS taking this step is a giant leap forward. From a purely commercial standpoint, it doesn't make any sense," said Robin Koval, president of the Legacy Foundation, a non-profit that focuses on ending smoking. "It's a conversation that's been going on for quite some time between public health groups and retailers, but progress has been very slow."

The company wants to define its pharmacies as full-fledged health-care providers and received praise from President Obama, himself a former smoker.

"As one of the largest retailers and pharmacies in America, CVS Caremark sets a powerful example, and today's decision will help advance my administration's efforts to reduce tobacco-related deaths, cancer, and heart disease, as well as bring down health care costs – ultimately saving lives and protecting untold numbers of families from pain and heartbreak for years to come," Obama said. "I congratulate – and thank – the CEO of CVS Caremark, Larry Merlo, the board of directors, and all who helped make a choice that will have a profoundly positive impact on the health of our country."

Shares were trading lower by 1.66 percent in the pre-market session.

Merck: Earnings miss

This morning, Merck (NYSE: MRK) reported its fourth quarter results. The company announced an EPS of $0.88, missing the consensus estimate of $0.89. Revenue of $11.32 billion missed the consensus estimate of $11.25 billion.

“In 2013 we took decisive action to sharpen our focus, reduce our cost structure and advance our innovative research and development,” said Kenneth C. Frazier, chairman and chief executive officer, Merck. “This year we are excited about the potential of our near- and long-term pipeline, poised for long-term growth and committed to providing continued value to patients, customers and our shareholders.”

Net profit for the quarter totaled $781 million, a 14 percent drop from last year's $980 million. Earnings were hurt by patent expiration as well as currency fluctuations.

Merck expects its 2014 EPS to be $3.35 to $3.53 with the consensus estimate coming in the mid-range at $3.48. Revenue is guided to be $42.4 billion to $43.2 billion, below the consensus estimate of $43.35 billion.

Shares were trading higher by 1.57 percent in the pre-market session.

Estee Lauder: Revenue miss

This morning, The Estee Lauder Companies (NYSE: EL) reported its second quarter results. The company announced an EPS of $1.09, beating the consensus estimate of $1.07. Revenue of $3.02 billion missed the consensus estimate of $2.98 billion.

“Our fiscal second quarter sales growth was in line with our expectations, despite softer than expected markets in some geographies,” said Fabrizido Freda, President and Chief Executive Officer. “Earnings per share exceeded our forecast, due to strong results in several of our brands and high margin channels, as well as our ability to leverage costs. These results confirm that our business strategy is sound and effective”

Estee Lauder saw strong revenue gains in the Americas as well as Europe/Middle East/Africa which helped to offset a six percent drop in sales in Asia during the quarter. Revenue in all segments rose except for Skin Care which dropped by one percent.

Shares were trading higher by 2.02 percent in the pre-market session.

Time Warner: Earnings report, mass firing on the horizon

This morning, Time Warner (NYSE: TWX) reported its fourth quarter results. The company announced an EPS of $1.17, beating the consensus estimate of $1.16. Revenue of $8.6 billion beat the consensus estimate of $8.36 billion.

Time Warner's revenue stream was steady over the quarter with HBO revenue increasing 2.9 percent to $1.26 billion, Turner segment revenue rose 5.8 percent to $2.55 billion and Warner Brothers segment revenue rising 7.3 percent to $3.996 billion.

Time Warner approve a new $5 billion share repurchase program to replace an expired authorization. The company ended the quarter with $3.5 billion in free cash flow.

Time Inc is expected to slash jobs to make the company look more attractive as ahead of its spinoff from Time Warner later this year. The company's CEO said that the number of firings will be large, as high as 500. The company said yesterday that it's best to “take the pain” all at once with a final announcement to occur very shortly.

Shares were trading higher by 2.16 percent in the pre-market session.

Posted-In: Abrizido Freda Christian Chabot cvs caremark CVS Tobacco Estee Lauder JMP Securities Kenneth C. FrazierNews Best of Benzinga

 

Related Articles (CVS + DATA)

Around the Web, We're Loving...

Get Benzinga's Newsletters